Board-certified physician and regenerative medicine pioneer brings over 28 years of clinical experience in stem cell therapies to Robles BioCeutics’ growing scientific leadership team.
SAN DIEGO, Sept. 2, 2025 /PRNewswire/ — Robles BioCeutics, a regenerative dermatology biotechnology company developing next-generation skincare solutions through stem cell-derived and senolytic technologies, is pleased to welcome Dr. Navneet Boddu to its Advisory Board.
Dr. Boddu is a Board-Certified Anesthesiologist and Pain Medicine Specialist with more than 28 years of clinical experience. He currently serves as the Founder and Medical Director of Advanced Pain & Regenerative Specialist, a leading medical clinic based in Oceanside, California. His practice specializes in non-surgical spine and joint care using evidence-based regenerative treatments, including autologous bone marrow stem cell therapy and platelet-rich plasma (PRP) injections. Dr. Boddu’s integrative approach combines regenerative medicine with traditional pain management to deliver patient-specific outcomes—anchored in the belief that each individual is their best advocate for healing.
Dr. Boddu completed his Pain Medicine Fellowship at the University of California, Davis Medical Center, and his Anesthesiology Residency at Loma Linda University, two institutions recognized for leadership in academic medicine and clinical innovation. His medical training laid the foundation for a career at the forefront of biologics and interventional regenerative therapies.
“Dr. Boddu‘s extensive clinical insight and expertise in regenerative therapies align perfectly with our vision for science-backed skin health,” said Maria Robles, CEO and President of Robles BioCeutics. “His deep understanding of biologics and patient-centered innovation will be instrumental in helping us bridge clinical practice with product development as we continue to redefine aging at the cellular level.”
“I‘m excited to join Maria and her team at Robles BioCeutics at such a pivotal stage in their growth,” said Dr. Navneet Boddu. “The science behind GlowSelle™ and the company‘s broader regenerative dermatology platform is compelling. To my knowledge, Robles BioCeutics is the only dermatology company to leverage Injury Mimetic Technology™ to realize the full potential of stem cells[1]. I look forward to advising the team as they translate these technologies into powerful solutions that can help people look and feel their best without invasive procedures.”
With Dr. Boddu‘s appointment, Robles BioCeutics continues to solidify its position at the intersection of regenerative medicine and dermatological innovation—while reaffirming its commitment to human safety as the foundation of all scientific progress. As the company advances toward clinical validation and commercialization, the growing strength of its Advisory Board reflects a deliberate focus on ethical development, scientific rigor, and strategic collaboration in pursuit of transformative, patient-centered skin health solutions.
About Robles BioCeutics
Robles BioCeutics is a regenerative dermatology company advancing the future of skin health through breakthrough technologies in senolytics and stem cell science. With a focus on cellular longevity and repair, we aim to transform the way aging is approached—topically and systemically.
For updates, follow Robles BioCeutics on Instagram, Twitter, Facebook, and Youtube, or visit us at www.roblesbioceutics.com
Media Contact:
Maria Robles, CEO and President
Robles BioCeutics
858-609-0948
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/robles-bioceutics-welcomes-top-ranked-regenerative-medicine-physician-dr-navneet-boddu-to-advisory-board-302543818.html
SOURCE Robles BioCeutics
